About UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro
During the past decade, UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro"
#1 collaborator was "Fondazione Adecco per le Pari Opportunità" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro
According to Clinical.Site data, the most researched conditions in "UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro" are
"Chronic Myeloid Leukemia" (7 trials), "Acute Promyelocytic Leukemia" (4 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Acute Lymphoblastic Leukemia" (2 trials) and "Leukemia" (2 trials). Many other conditions were trialed in "UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro" in a lesser frequency.
Clinical Trials Intervention Types at UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro
Most popular intervention types in "UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro" are "Drug" (18 trials), "Other" (6 trials), "Behavioral" (2 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ibrutinib" (2 trials), "Nilotinib" (2 trials), "all-trans retinoic acid (ATRA)" (2 trials), "Allogeneic SCT or Autologous SCT" (1 trials) and "Antibiotic and antifungal drugs" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro
The vast majority of trials in "UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro" are
27 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro
Currently, there are NaN active trials in "UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro".
undefined are not yet recruiting,
2 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 15 completed trials in UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro, 1 "Phase 1"
clinical trials were conducted, 14 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".